Showing results (141-150 of 166) with videos related to
Sort By:
Pageof 17
Haematologica|July 20, 2023
Fludarabine, cytarabine, and idarubicin with or without venetoclax in patients with relapsed/refractory acute myeloid leukemiaRabia Shahswar, Gernot Beutel, Razif Gabdoulline, et al.Ebiomedicine|June 7, 2022
A phase 2 trial of a topical antiseptic bundle in head and neck cancer surgery: Effects on surgical site infection and the oral microbiomeJoseph Zenga, Samantha Atkinson, Tina Yen, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2022
20-Year Steady Increase in Survival of Adult Patients with Relapsed Philadelphia-Positive Acute Lymphoblastic Leukemia Post Allogeneic Hematopoietic Cell TransplantationAli Bazarbachi, Myriam Labopin, Mahmoud Aljurf, et al.Bone Marrow Transplantation|November 9, 2021
Long-term results and GvHD after prophylactic and preemptive donor lymphocyte infusion after allogeneic stem cell transplantation for acute leukemiaChristoph Schmid, Myriam Labopin, Nicolaas Schaap, et al.The Lancet. Haematology|March 19, 2018
Long-term efficacy of reduced-intensity versus myeloablative conditioning before allogeneic haemopoietic cell transplantation in patients with acute myeloid leukaemia in first complete remission: retrospective follow-up of an open-label, randomised phase 3 trialFrederick Fasslrinner, Johannes Schetelig, Andreas Burchert, et al.Hemasphere|March 11, 2025
Cell-free DNA for detection and monitoring of extramedullary AML relapseHenri C Hupe, Clara P Wienecke, Stephan Bartels, et al.Blood|July 3, 2010
Allogeneic stem cell transplantation provides durable disease control in poor-risk chronic lymphocytic leukemia: long-term clinical and MRD results of the German CLL Study Group CLL3X trialPeter Dreger, Hartmut Döhner, Matthias Ritgen, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 20, 2021
Comparison Between 5-Azacytidine Treatment and Allogeneic Stem-Cell Transplantation in Elderly Patients With Advanced MDS According to Donor Availability (VidazaAllo Study)Nicolaus Kröger, Katja Sockel, Christine Wolschke, et al.Head & Neck|October 7, 2025
Tumoral Skin Invasion Is an Independent Predictor of Rapid Recurrence in Head and Neck CancerAbdullah A Memon, Mohamed Khalil, Oscar Villarreal Espinosa, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 27, 2014
Treatment of acute myeloid leukemia or myelodysplastic syndrome relapse after allogeneic stem cell transplantation with azacitidine and donor lymphocyte infusions--a retrospective multicenter analysis from the German Cooperative Transplant Study GroupThomas Schroeder, Elena Rachlis, Gesine Bug, et al.Pageof 17